FILE PHOTO: Sanofi full-year results FILE PHOTO: Sanofi logo at the company’s headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/File Photo Post navigation Previous: US Supreme Court spurns Sanofi appeal to revive EpiPen suit against Viatris